NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 59 filers reported holding NIVALIS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,000 | -97.8% | 1,200 | -89.4% | 0.00% | – |
| Q3 2016 | $91,000 | +15.2% | 11,287 | -34.6% | 0.00% | – |
| Q2 2016 | $79,000 | +2533.3% | 17,263 | +2245.5% | 0.00% | – |
| Q1 2016 | $3,000 | -66.7% | 736 | -40.6% | 0.00% | – |
| Q4 2015 | $9,000 | -50.0% | 1,239 | -10.7% | 0.00% | – |
| Q3 2015 | $18,000 | +80.0% | 1,388 | +105.6% | 0.00% | – |
| Q2 2015 | $10,000 | – | 675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|